Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
3.510
-0.040 (-1.13%)
At close: Jul 11, 2025, 4:00 PM
3.410
-0.100 (-2.85%)
After-hours: Jul 11, 2025, 7:58 PM EDT
Jasper Therapeutics Stock Forecast
JSPR's stock price has decreased by -82.34% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 12 analysts that cover Jasper Therapeutics stock have a consensus rating of "Buy" and an average price target of $31.67, which forecasts a 802.28% increase in the stock price over the next year. The lowest target is $4 and the highest is $65.
Price Target: $31.67 (+802.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Jasper Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 8 | 7 | 7 | 7 | 7 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy → Hold Downgrades $15 → $4 | Buy → Hold | Downgrades | $15 → $4 | +13.96% | Jul 8, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $70 → $12 | Buy | Maintains | $70 → $12 | +241.88% | Jul 8, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $50 → $20 | Buy | Maintains | $50 → $20 | +469.80% | Jul 8, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +469.80% | Jul 7, 2025 |
Financial Forecast
Revenue This Year
n/a
from 222.84M
Revenue Next Year
n/a
EPS This Year
-5.34
from -4.89
EPS Next Year
-5.37
from -5.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 46.2M | 10.5M | 24.1M | ||
| Avg | 5.6M | 1.5M | 4.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -79.3% | 87.2% | 1,552.9% | ||
| Avg | -97.5% | -74.0% | 233.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.61 | -2.33 | -4.06 | ||
| Avg | -5.34 | -5.37 | -6.10 | ||
| Low | -6.52 | -7.80 | -9.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.